Skip to main content
. 2012 May;166(2):689–701. doi: 10.1111/j.1476-5381.2011.01795.x

Figure 3.

Figure 3

Graphs show the effects of drugs with documented TdP risk on the commonly used surrogate marker for TdP risk (QTcB, % change from baseline; in blue) and on the E-M window (ms; in red). Quinidine, haloperidol, domperidone, terfenadine and thioridazine prolonged the QTcB interval and consistently decreased the E-M window. Graphs show mean ± SEM.